New Treatment Option for Patients at Risk of Sudden Cardiac Arrest

Published date : 29 October 2012
Article date : 29 October 2012


The Scaramento Bee reports on the FDA's approval of what they describe as 'the world's first subcutaneous implantable defibrillator' providing a new treatment option for patients who are at risk of sudden cardiac arrest. 

The S-ICD System, manufactured by Boston Scientific, has two main components. One is a pulse generator which powers the system, monitors heart activity and delivers a shock, if required. The second main component is an electrode that enables the device to sense the heart rhythm and deliver shocks when necessary. Both are implanted just under the skin, providing protection without touching the heart and reliable defibrillation without transvenous wires.

The Bluhm Cardiovascular Institute is one of the first ten places to implant in the US.

Source: The Sacramento Bee (, 25 October 2012

Read the original article here.

Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.